Dates not reported
Counsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020); Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018)
Federal government
Inspect source ↗Sourced institutional rolesLDA lobbying records
ANNABELL MCWHERTER STOKES
ANNABELL MCWHERTER STOKES appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Aug 31, 2026
Source-backed chronology
Career Timeline
Dates not reported
Registered lobbyist
Inspect source ↗Documented career transitions
Revolving Door
Congress → Lobbying
Federal governmentCounsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020); Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018)↓Palantir TechnologiesRegistered lobbyistFederal LDA filings
Lobbying Activity
PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2020
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2020
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software.
LDA filing ↗PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2020
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2022
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S. 3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2022
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administration's 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.
LDA filing ↗PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2021
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; and support funding for the Food and Drug Administrations 21Forward initiative.
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2020
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software.
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2021
Registrant: INVARIANT LLC · Health Issues
Discuss the federal governments use of Palantirs commercial software including efforts for the COVID-19 response; highlight commercial benefits of software solutions; highlight projects within HHS, NIH, and FDA; support federal funding for maintaining systems put in place for the COVID-19 response.
LDA filing ↗PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2022
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administrations 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.
LDA filing ↗PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2021
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗PALANTIR TECHNOLOGIES INC.3rd Quarter (July 1 - Sep 30) 2021
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; encourage support for maintaining systems put in place for COVID-19 to address future public health emergencies.
LDA filing ↗PALANTIR TECHNOLOGIES INC.4th Quarter (Oct 1 - Dec 31) 2022
Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support funding for the Food and Drug Administration's 21Forward Initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act; support funding for the National COVID Cohort Collaborative.
LDA filing ↗PALANTIR TECHNOLOGIES INC.1st Quarter (Jan 1 - Mar 31) 2023
Registrant: INVARIANT LLC · Health Issues
Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act.
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2023
Registrant: INVARIANT LLC · Health Issues
Support funding for the Food and Drug Administration 21 Forward Program, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act. Monitor Pandemic All Hazards Preparedness Act and related legislation, highlighting ongoing work with ASPR.
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2024
Registrant: INVARIANT LLC · Health Issues
Support funding for the National Institutes of Health N3C Program and Centers for Disease Control and Prevention Ready Response Data Integration Platform, and ASPR Supply Chain Control Tower. Provide recommendations for the reauthorization of the Pandemic All-Hazards Preparedness Act and related legislation, highlighting ongoing work at ASPR. Discuss improvements to the organ transplant network IT and software infrastructure. Highlight how Palantir's technology is being used by hospitals and health systems.
LDA filing ↗